Trial | NCT00502047  Report issue

Title

Effect of the Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia
Multicentre, Comparative, Double-Blind, Two-Arm Parallel Clinical Trial of the Effects of Treatment With Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia

  • Phase

    Phase 2/Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    255
The hypothesis of this study is that soluble fibre may contribute to a reduction of the low density lipoprotein cholesterol (LDL-c), and the combined effect with a statin may achieve an optimisation of the cholesterol-lowering effects in adults with several cardiovascular risk factors.
It has been demonstrated that high concentrations of cholesterol and low density lipoprotein cholesterol (LDL, high risk cholesterol) are the major risk factors for heart disease, myocardial infarction and angina pectoris. Moreover, these conditions represent the major cause of death in the Western world.

Of the measures established to reduce blood cholesterol levels, the introduction of consumption of dietary fibre is a novelty. The term dietary fibre defines a variety of substances that are found in plants and are resistant to digestion by human gastrointestinal enzymes.

The studies performed up until now to determine the effects of fibre on blood lipids have demonstrated that consumption of soluble fibre can reduce cholesterol.
Study Started
Sep 30
2005
Study Completion
Jul 31
2007
Last Update
Jul 17
2007
Estimate

Drug Plantago ovata husk

Criteria 

Inclusion Criteria:

Levels of LDL-c between >130 mg/dl and <189 mg/dl
Presence at least 1 of the cardiovascular risk factor defined as:
age above 45 years in men and 55 years in women
smoker
high blood pressure
HDL-c < 40 mg/dl in men and <46 mg/dl in women
family background of early heart disease
Patients who have given informed consent
Patients who will be capable of following diet guidelines

Exclusion Criteria:

Triglycerides >350 mg/dl

History of cardiovascular disease

treatment with statins prior to the beginning of the trial and who have not dropped out at least 2 months before the beginning of the study
Diabetes mellitus
No Results Posted